(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4 Pite ≥99.0% ee ≥99.0% Linagliptin Alogliptin Trelagliptin Entèmedyè
Pwovizyon komèsyal Alogliptin Benzoate (CAS: 850649-62-6) Entèmedyè ki gen rapò:
6-Chloro-3-methyluracil CAS: 4318-56-3
2-Cyanobenzyl Bromide CAS: 22115-41-9
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile CAS: 865758-96-9
Pwovizyon komèsyal Trelagliptin Succinate (CAS: 1029877-94-8) Entèmedyè ki gen rapò:
6-Chloro-3-Methyluracil CAS: 4318-56-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS: 334618-23-4
2-cyano-5-flurobenzyl bromur CAS: 421552-12-7
Non Chimik | (R)-(-)-3-Aminopiperidine Dihydrochloride |
Sinonim | (R)-(-)-3-Piperidinamine Dihydrochloride |
Nimewo CAS | 334618-23-4 |
Nimewo CAT | RF-PI140 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C5H12N2·2HCl |
Pwa molekilè | 173.08 |
Pwen k ap fonn | 190.0 ~ 195.0 ℃ |
Solibilite | Soluble nan dlo |
Kondisyon Shipping | Anba tanperati anbyen |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Blan Solid |
IR | Konfòme |
Pite chimik | ≥99.0% (HPLC) |
Nenpòt enpurte endividyèl | ≤0.20% |
Pite optik | ee ≥99.0% |
Imidite (KF) | ≤0.50% |
Rezid sou ignisyon | ≤0.10% |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Linagliptin, Alogliptin, Trelagliptin, Saxagliptin |
Pake: Boutèy, sak papye aliminyòm, 25kg/tanbou katon, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite.
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan (R)-(-)-3-Aminopiperidine Dihydrochloride (CAS: 334618-23-4) ak kalite siperyè, lajman ki itilize nan sentèz òganik, sentèz entèmedyè pharmaceutique. ak aktif engredyan pharmaceutique (API) sentèz, tankou Alogliptin Benzoate (CAS: 850649-62-6), Trelagliptin Succinate (CAS: 1029877-94-8), ak Linagliptin (CAS 668270-12-0).
Alogliptin Benzoate (CAS: 850649-62-6) se yon medikaman dyabèt tip-2, epi li se yon kalite serine protease dipeptidyl peptidase IV (DPP-4) inibitè.Alogliptin, ki itilize pou kont li oswa nan konbinezon ak lòt medikaman ki bese sik nan san, anjeneral byen tolere nan pasyan dyabèt tip 2.
Trelagliptin Succinate (CAS: 1029877-94-8) (SYR-472) se yon inibitè selektif, ki dire lontan dipeptidyl peptidase-4 (DPP-4) ki itilize pou tretman dyabèt tip 2.Yon ajan antidyabetik. Trelagliptin Succinate te apwouve pou itilize nan Japon an mas 2015.